Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT02836418 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Facioscapulohumeral Muscular Dystrophy
Limb Girdle Muscular Dystrophy

Interventions

DRUG: ATYR1940

Sponsor

aTyr Pharma, Inc.